ArticleFrontiers in endocrinology2022

Benign thyroid nodules respond to a single administration of 0.3mg recombinant human thyrotropin with highly variable volume increase.

Panagiotis Bountouris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.